1. Abah SJ et al. (2005). There's hope - early observations of ARV treatment roll out in South Africa. Essential Drugs Monitor No.34:16-17.
2. Adome RO, Reynolds-Whyte S, Hardon A (1996). Popular pills. Community drug use in Uganda. Community Drug Use Studies. Amsterdam, Het Spinhuis, 1996.
3. Birungi, H. Injection use and practices in Uganda. Geneva, World Health Organization, 1995.
4. Farmer KC (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, 21(6):1074-1090.
5. Haaland A, Molyneux C. Collecting quality information: training manual on practical communication skills for researchers and project personnel. Geneva, World Health Organization, 2005.
6. Hardon A. Confronting ill health: medicines, self-care and the poor in Manila. Quezon City, Health Action Information Network, 1990.
7. Hardon AP, Hodgkin C, Fresle D (2004). How to investigate the use of medicines by consumers. Geneva, World Health Organization, 2004.
8. Hardon A et al. Manual for applied health research. Anthropology of health and health care. Amsterdam, Het Spinhuis, 2001.
9. Hogerzeil HV et al.(1993). Field tests for rational drug use in twelve developing countries. Lancet, 4 December:1408-1410.
10. Kasper T et al. (2003). Demystifying antiretroviral therapy in resource-poor settings. World Health Organization Essential Drugs Monitor No.32:20-21.
11. Paterson DL et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133:21-30.
12. Population Council Horizons (2005). Testing different approaches to promoting adherence to HAART in Mombasa, Kenya. Available at: http://www.popcouncil.org/horizons/AIDSquest/summaries/ssmombasaARVs.html
13. Rasmussen ZA et al. Enhancing appropriate medicine use in the Karakoram mountains. Community Drug Use Studies. Amsterdam, Het Spinhuis, 1996.
14. Richard N et al. (2004). High prevalence of antiretroviral resistance in treated Ugandans infected with Non-subtype B Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses, 20(4):355-364.
15. Sankar A et al. (2002). Adherence discourse among African-American women taking HAART. AIDS Care, 14(2):203-218.
16. Senah KA. The popularity of medicines in a rural Ghanaian community. Community drug use studies. Amsterdam, Het Spinhuis, 1997.
17. Sringernyuang L. Availability and use of medicines in rural Thailand. University of Amsterdam, 2000 [Dissertation].
18. van Staa A, Hardon A. Injection practices in the developing world: a comparative review of field studies in Uganda and Indonesia. Geneva, World Health Organization, 1996.
19. Vitolins MZ et al. (2000). Measuring adherence to behavioral and medical interventions. Controlled Clinical Trials, 21:188S-194S.
20. WHO (1985). Rational use of drugs. Report of the Conference of Experts, Nairobi, Kenya, 25-29 November. Geneva, World Health Organization.
21. WHO (1992). How to investigate drug use in communities. Geneva, World Health Organization.
22. WHO (1993). How to investigate drug use in health facilities. Geneva, World Health Organization.
23. WHO (1997). Public education in rational drug use. Geneva, World Health Organization.
24. WHO (2002). Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines, No.5. Geneva, World Health Organization.